The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program

BACKGROUND: While treatment with levodopa remains the cornerstone of Parkinson's disease (PD) management, chronic oral therapy is often associated with the development of motor complications, that correlate to fluctuating levodopa plasma concentrations, limiting its clinical utility. Continuous...

Descripción completa

Detalles Bibliográficos
Autores principales: LeWitt, Peter A., Stocchi, Fabrizio, Arkadir, David, Caraco, Yoseph, Adar, Liat, Perlstein, Itay, Case, Ryan, Giladi, Nir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686322/
https://www.ncbi.nlm.nih.gov/pubmed/36438968
http://dx.doi.org/10.3389/fneur.2022.1036068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686322/
https://www.ncbi.nlm.nih.gov/pubmed/36438968
http://dx.doi.org/10.3389/fneur.2022.1036068

Ejemplares similares